Rheumatoid Arthritis Market Therapy Analysis and Epidemiology Forecast Report to 2025
EpiCast Report: Rheumatoid Arthritis – Epidemiology Forecast to 2025 report provide an overview of the risk factors and global trends of RA in the eight major markets (8MM) (US, France, Germany, Italy, Spain, UK, Japan, and Australia).
June 5, 2017 /MarketersMedia/ —
RnRMarketResearch.com added new research report on EpiCast Report: Rheumatoid Arthritis – Epidemiology Forecast to 2025. Rheumatoid arthritis (RA) is an autoimmune disease characterized by inflammation of the joints, bone and cartilage erosion, and joint deformity. Additionally, the condition manifests itself in multiple joints in the body (CDC, 2015; Mayo Clinic, 2016). In RA, the body’s immune system attacks the lining of the joints, known as the synovial membrane, or synovium, causing an inflammatory response (CDC, 2015). The disease can lead to premature mortality, disability, and decreased quality of life.
Rheumatoid Arthritis Market report has 17 Tables and 13 Figures, Spread across 62 Pages Report Available at http://www.rnrmarketresearch.com/epicast-report-rheumatoid-arthritis-epidemiology-forecast-to-2025-market-report.html .
In the 8MM, epidemiologists forecast that the diagnosed incident cases of RA will increase from 195,592 cases in 2015 to 216,467 cases in 2025, at an Annual Growth Rate (AGR) of 1.07%. The US will have the highest number of diagnosed incident cases of RA among the 8MM throughout the forecast period, while Spain will have the lowest.
Epidemiologists forecast that the diagnosed prevalent cases of RA will increase from 4,354,194 cases in 2015 to 4,931,572 cases in 2025, at an AGR of 1.33%. The US will have the highest number of diagnosed prevalent cases of RA among the 8MM throughout the forecast period, while Australia will have the lowest.
Discount Available at http://www.rnrmarketresearch.com/contacts/discount?rname=838182 .
The report “EpiCast Report: Rheumatoid Arthritis – Epidemiology Forecast to 2025” provide an overview of the risk factors and global trends of RA in the eight major markets (8MM) (US, France, Germany, Italy, Spain, UK, Japan, and Australia). It includes a 10-year epidemiological forecast for the diagnosed incident cases, diagnosed prevalent cases, and total prevalent cases of RA segmented by age and sex in these eight markets. The diagnosed prevalent cases of RA are further segmented by severity in the 8 MM for the forecast period.
Table of Contents
Disease Background
Risk Factors and Comorbidities
Global Trends
Diagnosed Incidence
Prevalence
Forecast Methodology
Sources Used
Forecast Assumptions and Methods
Sources Not Used
Epidemiological Forecast for RA (2015-2025)
Diagnosed Incident Cases
Diagnosed Prevalent Cases
Total Prevalent Cases
Discussion
Epidemiological Forecast Insight
Limitations of the Analysis
Strengths of the Analysis
Order a copy of this research report at http://www.rnrmarketresearch.com/contacts/purchase?rname=838182 .
Appendix
Bibliography
Physicians and Specialists Included in this Study
About the Authors
Epidemiologist
Reviewers
Global Director of Therapy Analysis and Epidemiology
About EpiCast
Disclaimer
List of Tables.
List of Figures.
Related Report
PharmaPoint: Rheumatoid Arthritis – Global Drug Forecast and Market Analysis to 2025 : The report overview of rheumatoid arthritis (RA), including etiology, pathophysiology, and country-specific diagnosis and treatment recommendations. Companies mentioned in this report: AbbVie, Pfizer, Amgen, Johnson & Johnson, Eli Lilly, Bristol-Myers Squibb, UCB, Roche, GlaxoSmithKline, Novartis, Sanofi, AstraZeneca-MedImmune, Astellas, Daiichi Sankyo, Samsung Bioepis, Sandoz.
About Us:
RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports. Call +1 888 391 5441 with your research requirements or email the details at sales@rnrmarketresearch.com.
Contact Info:
Name: Ritesh Tiwari
Email: sales@rnrmarketresearch.com
Organization: RnRMarketResearch.com
Phone: +1 888 391 5441
For more information, please visit http://www.rnrmarketresearch.com/epicast-report-rheumatoid-arthritis-epidemiology-forecast-to-2025-market-report.html
Source: MarketersMedia
Release ID: 205022
Copyright © 1999-2013 SproutNews.com
